Atricure to host analyst & investor day on march 26, 2025

Mason, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in surgical treatments and therapies for atrial fibrillation (afib), left atrial appendage (laa) management, and post-operative pain management, today reaffirmed that the company will host an analyst & investor day at its headquarters in mason, ohio on wednesday, march 26, 2025 from 1:00 pm to 4:00 pm et. “our team is excited to highlight our leading portfolio of products and innovative pipeline for market expa.
ATRC Ratings Summary
ATRC Quant Ranking